| DC9826 |
BCTC
Featured
|
BCTC is a potent and specific inhibitor of transient receptor potential cation channel subfamily M member 8 (TRPM8) in prostate cancer (PCa) DU145 cells. |
|
| DC8313 |
BD1047.2HBr
Featured
|
BD 1047 dihydrobromide is a selective antagonist of σ receptors. |
|
| DC23499 |
BD-1047
Featured
|
BD-1047 is a potent, selecitve Sigma 1 receptor (σ1) antagonist with Ki of 0.93 nM. |
|
| DC10280 |
BD1063 dhydrochloride
Featured
|
BD1063 dhydrochloride is a potent and selective sigma 1 receptor antagonist. |
|
| DC9709 |
BDA-366
Featured
|
BDA-366 is a Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. |
|
| DC21101 |
BDCRB
Featured
|
BDCRB (GW 275175) is a potent and selective inhibitor of human CMV replication by blocking the processing and maturation of viral DNA.. |
|
| DC10860 |
BDP5290
Featured
|
BDP5290 is a potent inhibitor of both ROCK and MRCK with IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively. |
|
| DC20765 |
BDT001
Featured
|
BDT001 is a first-in-class, non-competitive FLT3 negative allosteric modulator, effectively prevents extracellular cytokine FL binding to FLT3 with IC50 of 11 uM. |
|
| DC9718 |
BEBT-908（CUDC-908）
Featured
|
BEBT-908（CUDC-908）is a novel PI3K/HDAC inhibitor. |
|
| DC9964 |
BEC hydrochloride
Featured
|
BEC is a boronic acid-based arginine analog that acts as a slow-binding, competitive transition state inhibitor of arginase I and II (Ki = 310 nM for human recombinant type II arginase, pH 7.5). |
|
| DC8809 |
Bedaquiline fumarate
Featured
|
Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
|
| DC21007 |
Befiradol
Featured
|
Befiradol (F13640, NLX 112) is a highly potent, selective 5-HT1A receptor agonist with Ki of 2.7 nM. |
|
| DC7082 |
Belinostat (PXD101)
Featured
|
Belinostat (PXD101) is a novel pan-HDAC inhibitor with IC50 of 27 nM, with activity demonstrated in cisplatin-resistant tumors. |
|
| DC10448 |
Belizatinib(TSR-011)
Featured
|
Belizatinib(TSR-011) is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity. |
|
| DC11470 |
Belotecan hydrochloride(CKD-602)
Featured
|
Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic and water-soluble camptothecin derivative. |
|
| DC12278 |
Belvarafenib
Featured
|
Belvarafenib is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively. |
|
| DC6908 |
Bendamustine HCL (SDX-105, Cytostasane)
Featured
|
Bendamustine HCL (Ribomustin, Treanda, SDX-105) is a DNA-damaging agent with IC50 of 50 μM. |
|
| DC10701 |
Benzamide (NSC 404988)
Featured
|
Benzamide (NSC 404988) is a bioactive compound. |
|
| DC26053 |
Benzamil (hydrochloride)
Featured
|
Benzamil hydrochloride is a specific and potent sodium channel (ENaC) blocker. |
|
| DC8895 |
benzbromaron
Featured
|
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout. |
|
| DC20028 |
Benznidazole (Synonyms: Benznidazol; Ro 07-1051; Ro 71051)
Featured
|
Benznidazole (Ro 07-1051) is an antiparasitic medication, with an IC50 of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease. |
|
| DCAPI1500 |
Bepotastine Besilate
Featured
|
Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist. |
|
| DC8898 |
Bepotastine
Featured
|
Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. |
|
| DC11403 |
Bepridil hydrochloride
Featured
|
Bepridil hydrochloride is a calcium channel blocker, with antianginal activity. |
|
| DC4143 |
Besifloxacin HCl
Featured
|
Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic. |
|
| DC21382 |
EIDD-1931(NHC)
Featured
|
EIDD-1931 (β-d-N4-Hydroxycytidine, NHC) inhibits both murine hepatitis virus (MHV) (EC50 of 0.17 μM) and Middle East respiratory syndrome CoV (MERS-CoV) (EC50 of 0.56 μM) with minimal cytotoxicity. It also inhibits SARS-CoV-2 and multiple 2 endemic, epide |
|
| DC10655 |
3-Guanidinopropionic acid
Featured
|
Beta-guanidinopropionic acid is a novel creatine kinase inhibitor. |
|
| DC8830 |
Betahistine
Featured
|
Betahistine is a strong affinity histamine H3 receptor antagonist and weak affinity agonist of histamine H1 receptors. |
|
| DC7905 |
beta-Lapachone (ARQ-501, CO-501)
Featured
|
Beta-Lapachone is a selective DNA topoisomerase I inhibitor, exhibiting no inhibitory activities against DNA topoisomerase II or ligase. Phase 2. |
|
| DC11105 |
Umibecestat
Featured
|
beta-secretase inhibitor. |
|
